Investment Forecasts News 3 December 2025

Canaan Inc (CAN) Stock: BTIG Buy Rating, Green Bitcoin Pivot and 2026 Forecasts — December 8, 2025

Canaan Inc. (NASDAQ: CAN), the Bitcoin mining hardware maker turned vertically integrated miner, is back in the spotlight on December 8, 2025 after BTIG launched coverage with a Buy rating and a $3.00 price target, implying several hundred percent upside

8 December 2025

Financial News·Green Technology·Investment Forecasts·Stock Analysis

Genting Singapore (SGX:G13) on 8 December 2025: Share Price, Q3 2025 Results, RWS 2.0 Expansion and 2026 Forecasts

Genting Singapore Limited, the operator of Resorts World Sentosa (RWS) and a heavyweight on the Straits Times Index, is in an interesting spot on 8 December 2025: fundamentals and tourism recovery are improving, yet the share price is still treading

8 December 2025

Earnings Reports·Investment Forecasts·Singapore Market·Stock Analysis

Nebius Group NV (NBIS) Stock on December 6, 2025: Price, Microsoft & Meta Megadeals, Q3 Results and 2026 Forecasts

Nebius Group N.V. (NASDAQ: NBIS) has quickly become one of the most talked‑about names in the AI infrastructure “neocloud” trade. As of December 6, 2025, the stock is well off its October peak but still massively ahead of where it

6 December 2025

Earnings Reports·Financial Analysis·Investment Forecasts·Stock Market·Tech Industry

National Australia Bank (ASX:NAB) Share Price on 5 December 2025: Dividend Yield, FY25 Results and Stock Forecast

National Australia Bank Limited (ASX:NAB) shares are trading around A$40.6–A$40.7 on Friday, 5 December 2025, nudging higher after a volatile November as investors weigh a solid dividend stream against slower profit growth and a richer valuation multiple. StockAnalysis According to

5 December 2025

Dividend Investing·Investment Forecasts·Stock Market Analysis

Praxis Precision Medicines (PRAX) Stock Surges on FDA Progress and Epilepsy Trial Wins: Latest News and 2026 Forecast

Updated December 5, 2025 – all developments since December 4, 2025 Praxis Precision Medicines, Inc. (NASDAQ: PRAX) has moved back into the market spotlight after a flurry of major announcements on December 4, 2025. The biotech’s stock — already one

5 December 2025

Biotech News·FDA Updates·Investment Forecasts·Stock Market

Rigetti Computing (RGTI) Stock on December 4, 2025: Q3 Earnings Shock, Quantum Roadmap and 2026–2027 Forecasts

Rigetti Computing, Inc. (NASDAQ: RGTI) remains one of 2025’s wildest stories in quantum computing and in the broader U.S. stock market. After rocketing from penny‑stock territory in 2023 to a 2025 high above $58, the stock has just endured a

4 December 2025

Earnings Reports·Investment Forecasts·Quantum Computing·Stock Analysis·Technology Trends

Incannex Healthcare (IXHL) Stock Soars on FDA Fast Track: December 2025 Outlook, Forecast & Key Risks

Incannex Healthcare Inc. (Nasdaq: IXHL) is back on traders’ radar after the U.S. Food and Drug Administration granted Fast Track designation to its lead sleep-apnoea drug candidate, IHL‑42X. The move caps a busy 2025 that also brought strong Phase 2

4 December 2025

FDA News·Healthcare Stocks·Investment Forecasts·Risk Analysis·Stock Market

Robinhood Stock (HOOD) Jumps on Crypto Rebound: Latest News, Earnings Beat and 2026 Forecast – 4 December 2025

Robinhood Markets, Inc. (NASDAQ: HOOD) is back in the spotlight. On Thursday, 4 December 2025, HOOD is trading around $133–134 per share, up roughly 6% on the day, after another crypto‑driven surge in trading activity. That puts Robinhood’s market value

4 December 2025

Cryptocurrency·Earnings Reports·Financial News·Investment Forecasts·Stock Market

Marvell Technology (MRVL) Soars on Celestial AI Deal: Latest Earnings, Analyst Upgrades and 2026 Stock Forecast

Updated: December 4, 2025 Marvell Technology, Inc. (NASDAQ: MRVL) is back in the market spotlight. The AI‑focused chip designer has just delivered record quarterly results, unveiled a $3.25 billion acquisition of photonics startup Celestial AI, and triggered a wave of

4 December 2025

Analyst Ratings·Earnings Reports·Investment Forecasts·Stock Market·Technology

Pro Medicus (ASX: PME) Share Price Update: Data Breach Explained, New US Contracts and 2026 Stock Forecast

Published: 4 December 2025 Pro Medicus share price today Pro Medicus Limited (ASX: PME), the $27‑billion Australian healthcare imaging software group, is trading around A$253–255 per share in Thursday trade, slightly lower on the session after the company confirmed details

4 December 2025

Company Updates·Data Security·Investment Forecasts·Stock Analysis

CSL Limited (ASX:CSL) Share Price on 4 December 2025: Restructuring Fallout, New Vaccine Plant and 2026 Stock Forecast

Updated: 4 December 2025 CSL Limited (ASX:CSL), the Australian biotech heavyweight, is trading around A$183 per share on 4 December 2025 after one of the most bruising years in its modern history. The company has delivered solid profit growth, announced

4 December 2025

ASX Updates·Company Analysis·Healthcare Industry·Investment Forecasts

Amphenol Corporation (APH) Stock on December 3, 2025: AI Datacenter Deals, Insider Sales and Wall Street Forecasts

Amphenol Corporation (NYSE: APH) remains one of the standout performers in large-cap technology hardware as of December 3, 2025, powered by the AI datacenter boom, aggressive M&A and strong institutional demand – but also carrying a valuation that many analysts

3 December 2025

AI Technology·Company Analysis·Insider Trading·Investment Forecasts·Stock Market

Investment Forecasts News 3 December 2025 - 8 December 2025